A team building diagnostic tests for women's health.
Rea Diagnostics is a clinical-stage company developing diagnostic tests for women's health, with a first clinical program in preterm birth. The company is a spin-off of the École polytechnique fédérale de Lausanne (EPFL) and Lausanne University Hospital (CHUV), and is based at the EPFL Innovation Park in Lausanne, Switzerland.
The team.
Loulia Kassem
MSc Pharmaceutical Biotechnology, University of Bologna. Forbes 30 Under 30 Europe, Science & Healthcare (2022). Two-time founder.
LinkedIn →
Erick Garcia-Cordero, PhD
PhD in microtechnology, EPFL. Expert in biosensors for diagnostic applications.
LinkedIn →
Eric Klasen
Former VP Regulatory Affairs & Quality at Medtronic. Former Head of Global Drug Regulatory Affairs at Novartis.
Pierre-Emmanuel Thiriet
PhD, EPFL, with research at Stanford and UC Berkeley.
Prof. Carlotta Guiducci
Professor at EPFL, expert in biosensors for human health.
Fabien Rebeaud, PhD
PhD Biochemistry. Expert in IVD regulatory approvals, quality management systems, and clinical trial site operations.
Prof. David Baud, MD, PhD
Head of Obstetrics, Lausanne University Hospital (CHUV). Scientific collaborator on Rea's preterm birth research program.
Backed by the scientific and entrepreneurial community.
Rea's scientific and commercial development has been supported by competitive grants from leading research foundations and public innovation agencies, and recognised by entrepreneurship programmes across Europe and North America.
Work with us.
We are always interested in meeting scientists, engineers, and clinical and regulatory professionals who share our mission. If you would like to work with us, please contact us at contact@readiagnostics.com.
For students and early-career researchers, we also run an Early Careers Program with master thesis, post-master, and industrial internship tracks.